Williams F M, Asad S I, Lessof M H, Rawlins M D
Wolfson Unit of Clinical Pharmacology, University of Newcastle upon Tyne, UK.
Eur J Clin Pharmacol. 1987;33(4):387-90. doi: 10.1007/BF00637635.
Plasma aspirin esterase activity and cholinesterase activity were reduced in patients with aspirin sensitive asthma and aspirin sensitive urticaria compared to asthmatic and dermatological controls. Phenylacetate (non specific) esterase activities, were however unaltered in these patients. The reason for the lower activity is uncertain but it does not appear to be due to genetically determined lower cholinesterase or due to the avoidance of aspirin by sensitive patients. A low aspirin esterase activity may be a contributory factor in precipitating these aspirin sensitive reactions.
与哮喘和皮肤病对照组相比,阿司匹林敏感性哮喘和阿司匹林敏感性荨麻疹患者的血浆阿司匹林酯酶活性和胆碱酯酶活性降低。然而,这些患者的苯乙酸(非特异性)酯酶活性未发生改变。活性较低的原因尚不确定,但似乎不是由于基因决定的胆碱酯酶较低,也不是由于敏感患者避免使用阿司匹林。低阿司匹林酯酶活性可能是引发这些阿司匹林敏感反应的一个促成因素。